A retrospective study of 106 treatment-naive primary colorectal cancers compared FDG uptake parameters among RAS-mutant, BRAF-mutant, and RAS/BRAF double-wild-type tumors, finding distinct metabolic phenotypes across molecular subgroups. (J Clin Med)
FDG-PET Metabolic Patterns Differ Across RAS, BRAF, and Wild-Type Tumors
The CRC Digest